affordable tirzepatide weight loss program in ga Patient Educational Sheet GLP-1 Injection Instructions Handout Medspa Printable for Weight Loss Journey Info Tirzepatide Weight Loss | Atlanta

Patients should seek immediate medical attention for severe abdominal pain (possible pancreatitis), persistent vomiting leading to dehydration, or symptoms of significant hyperglycemia

According to FDA prescribing information, these effects vary by product and dose: For Ozempic (diabetes treatment): Nausea (15-20% of patients) Diarrhea (8-9% of patients) Vomiting (5-9% of patients) Constipation (3-7% of patients) Abdominal pain (5-6% of patients) For Wegovy (weight management), gastrointestinal effects are more common at the higher therapeutic dose: Nausea (up to 44% of patients) Diarrhea (up to 30% of patients) Vomiting (up to 24% of patients) Constipation (up to 24% of patients) Abdominal pain (up to 20% of patients) These effects are generally mild to moderate and tend to diminish with continued use

It is possible that this insight may lead to new approaches to prevention and therapy for COVID-19

Clinical evidence shows an average weight loss of 15 to 20 percent over 72 weeks, meaning for someone weighing 250 pounds, this could translate to a 37 to 50-pound weight reduction